US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist
  • 25.300
  • +6.050+31.43%
Close Apr 26 16:00 ET
  • 25.450
  • +0.150+0.59%
Post 19:50 ET
1.09BMarket Cap-6856P/E (TTM)

About Cullinan Therapeutics Company

Cullinan Management, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.

Company Profile

SymbolCGEM
Company NameCullinan Therapeutics
Listing DateJan 8, 2021
Issue Price21.00
Founded2016
CEOMr. Nadim Ahmed
MarketNASDAQ
Employees85
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Main Street,Suite 520
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-410-4650
Websitehttps://www.cullinanoncology.com/

Company Executives

  • Name
  • Position
  • Salary
  • Nadim Ahmed
  • Director, President and Chief Executive Officer
  • 3.90M
  • Jeffrey Trigilio
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • 1.92M
  • Dr. Corinne Savill, PhD
  • Chief Business Officer
  • --
  • Jeffrey Alan Jones
  • Chief Medical Officer
  • --
  • Dr. Jennifer Michaelson, PhD
  • Chief Scientific Officer
  • --
  • Jacquelyn L. Sumer
  • Chief Legal Officer, Chief Compliance Officer and Secretary
  • --
  • Anthony Rosenberg
  • Chairman of the Board
  • 236.42K
  • Anne-Marie Martin
  • Independent Director
  • 349.99K
  • Thomas Ebeling
  • Independent Director
  • 200.42K
  • Stephen W. Webster
  • Independent Director
  • 208.92K
  • David P. Ryan
  • Independent Director
  • 256.66K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg